3,292 Shares in Molina Healthcare, Inc $MOH Acquired by AG2R LA Mondiale Gestion D Actifs

Key Points

• AG2R LA Mondiale Gestion D Actifs acquired 3,292 shares of Molina Healthcare, valued at approximately $1,004,000, highlighting growing institutional interest in the stock.
• Following recent performance, several analysts have downgraded their price targets for Molina Healthcare, with UBS Group reducing theirs from $260 to $180, indicating a consensus average price target of $225.18.
• Molina Healthcare reported a Q2 EPS of $5.48, slightly missing analysts' expectations, while achieving a 15.7% year-over-year revenue increase to $11.43 billion.

AG2R LA Mondiale Gestion D Actifs purchased a new stake in Molina Healthcare, Inc (NYSE:MOH - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 3,292 shares of the company's stock, valued at approximately $1,004,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Rothschild Investment LLC raised its position in Molina Healthcare by 126.3% in the 1st quarter. Rothschild Investment LLC now owns 86 shares of the company's stock valued at $28,000 after buying an additional 48 shares during the last quarter. Zions Bancorporation National Association UT bought a new position in Molina Healthcare in the 1st quarter valued at $29,000. Deseret Mutual Benefit Administrators grew its stake in Molina Healthcare by 60.7% in the 1st quarter. Deseret Mutual Benefit Administrators now owns 90 shares of the company's stock valued at $30,000 after purchasing an additional 34 shares during the period. Elequin Capital LP grew its stake in Molina Healthcare by 170.6% in the 1st quarter. Elequin Capital LP now owns 92 shares of the company's stock valued at $30,000 after purchasing an additional 58 shares during the period. Finally, Silver Oak Securities Incorporated bought a new position in Molina Healthcare in the 1st quarter valued at $34,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

MOH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. reduced their price objective on Molina Healthcare from $272.00 to $184.00 and set a "neutral" rating for the company in a research note on Tuesday, July 29th. Cantor Fitzgerald restated a "neutral" rating and issued a $210.00 price objective on shares of Molina Healthcare in a research note on Tuesday, August 26th. Mizuho cut their price target on Molina Healthcare from $400.00 to $330.00 and set an "outperform" rating for the company in a research note on Friday, July 11th. Sanford C. Bernstein cut their price target on Molina Healthcare from $284.00 to $220.00 and set an "outperform" rating for the company in a research note on Friday, September 5th. Finally, Wall Street Zen downgraded Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Three investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $225.18.

Insiders Place Their Bets

In related news, Director Ronna Romney sold 700 shares of the business's stock in a transaction that occurred on Wednesday, August 6th. The stock was sold at an average price of $153.74, for a total value of $107,618.00. Following the completion of the sale, the director owned 17,131 shares in the company, valued at $2,633,719.94. The trade was a 3.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO James Woys bought 10,000 shares of the company's stock in a transaction that occurred on Monday, August 4th. The stock was purchased at an average price of $155.94 per share, with a total value of $1,559,400.00. Following the transaction, the chief operating officer directly owned 74,331 shares in the company, valued at $11,591,176.14. The trade was a 15.54% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.26% of the stock is owned by corporate insiders.

Molina Healthcare Price Performance

Shares of NYSE:MOH traded up $0.36 on Tuesday, hitting $176.47. The company's stock had a trading volume of 861,628 shares, compared to its average volume of 1,368,777. The company has a market capitalization of $9.56 billion, a PE ratio of 8.70 and a beta of 0.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.66 and a quick ratio of 1.66. The company has a 50-day simple moving average of $177.21 and a 200 day simple moving average of $264.38. Molina Healthcare, Inc has a 1 year low of $151.95 and a 1 year high of $361.80.

Molina Healthcare (NYSE:MOH - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The company reported $5.48 earnings per share for the quarter, missing analysts' consensus estimates of $5.50 by ($0.02). The company had revenue of $11.43 billion during the quarter, compared to analysts' expectations of $10.94 billion. Molina Healthcare had a net margin of 2.60% and a return on equity of 27.72%. The company's revenue for the quarter was up 15.7% compared to the same quarter last year. During the same period in the prior year, the business earned $5.86 earnings per share. Sell-side analysts forecast that Molina Healthcare, Inc will post 24.4 EPS for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.